Credit risk on trade receivables
First written in FY2017. 4 of 7 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2026: 18 of 64 companies on the "Worse" side.
- FY2026MitigatedAnnual report
「As of the consolidated fiscal year-end, 31.1% of trade receivables were from a specific major customer.」
The concentration of trade receivables in a specific major customer declined from 80.5% in the previous disclosure to 31.1%. - FY2025WorsenedAnnual report
「As of the consolidated fiscal year-end, 80.5% of trade receivables were attributable to a specific major customer.」
The concentration of 80.5% of trade receivables in a specific major customer is quantified for the first time, explicitly highlighting the concentration of credit risk. - FY2023RestatedAnnual report
「Trade receivables are exposed to customers' credit risk. However, our main customers are primarily highly creditworthy pharmaceutical companies and public research institutions.」
The credit risk of trade receivables and management based on the creditworthiness and monitoring of major customers are reconfirmed. - FY2020RestatedAnnual report
「Trade receivables are exposed to customers' credit risk. However, our main customers are primarily highly creditworthy pharmaceutical companies and public research institutions.」
The credit risk of trade receivables and management based on the creditworthiness and monitoring of major customers are reconfirmed. - FY2019RestatedAnnual report
「Trade receivables are exposed to customers' credit risk. However, our main customers are primarily highly creditworthy pharmaceutical companies and public research institutions.」
The credit risk of trade receivables and management based on the creditworthiness and monitoring of major customers are reconfirmed. - FY2018RestatedAnnual report
「Trade receivables are exposed to customers' credit risk. However, our main customers are primarily highly creditworthy pharmaceutical companies and public research institutions.」
The credit risk of trade receivables and management based on the creditworthiness and monitoring of major customers are reconfirmed. - FY2017First statedAnnual report
「Trade receivables are exposed to customers' credit risk. However, our main customers are primarily highly creditworthy pharmaceutical companies and public research institutions.」
Credit risk arising from customer default and deterioration in credit quality is disclosed for trade receivables, together with management based on the creditworthiness and monitoring of major customers.